<DrugInformationSummary id="CDR0000800196"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Enfortumab vedotin-ejfv is a type of drug called an antibody-drug conjugate. Antibody-drug conjugates consist of a monoclonal antibody chemically linked to a cancer-killing drug. The monoclonal antibody binds to a protein on the surface of some cancer cells. The linked drug enters these cancer cells and kills them. Enfortumab vedotin-ejfv may also stimulate the immune system to kill cancer cells. It is a type of targeted therapy.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/enfortumabvedotin-ejfv">Enfortumab Vedotin-ejfv</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000759429">enfortumab vedotin-ejfv</TerminologyLink><GlossaryLink ref="CDR0000800193">enfortumab vedotin</GlossaryLink><USBrandNames><USBrandName>Padcev</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>en-FOR-too-mab veh-DOH-tin</TermPronunciation><MediaLink ref="CDR0000801128" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000801129" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b5631d3e-4604-4363-8f20-11dfc5a4a8ed&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Enfortumab Vedotin-ejfv</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b5631d3e-4604-4363-8f20-11dfc5a4a8ed&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_6"><Title>Use in Cancer</Title>                                                              
  <Para id="_7">Enfortumab vedotin-ejfv
         is approved to treat:</Para>                          
  <ItemizedList Style="bullet" id="_8">
   <ListItem><Strong><GlossaryTermRef href="CDR0000783188" dictionary="Cancer.gov" audience="Patient">Urothelial cancer</GlossaryTermRef></Strong> (a type of cancer in the <GlossaryTermRef href="CDR0000046501" dictionary="Cancer.gov" audience="Patient">bladder</GlossaryTermRef> or <GlossaryTermRef href="CDR0000046095" dictionary="Cancer.gov" audience="Patient">urinary tract</GlossaryTermRef>) that has spread. It is used:<ItemizedList Style="bullet" id="_10"><ListItem>Alone in adults whose cancer cannot be removed by surgery and who have received <GlossaryTermRef href="CDR0000045841" dictionary="Cancer.gov" audience="Patient">platinum</GlossaryTermRef> chemotherapy and <GlossaryTermRef href="CDR0000045729" dictionary="Cancer.gov" audience="Patient">immunotherapy</GlossaryTermRef>.</ListItem><ListItem>Alone in adults whose cancer cannot be removed by surgery and who have received at least one other type of treatment and cannot receive <GlossaryTermRef href="CDR0000045230" dictionary="Cancer.gov" audience="Patient">cisplatin</GlossaryTermRef>.</ListItem><ListItem>With <GlossaryTermRef href="CDR0000764538" dictionary="Cancer.gov" audience="Patient">pembrolizumab</GlossaryTermRef> in adults who cannot receive  cisplatin.</ListItem></ItemizedList>  </ListItem>
   </ItemizedList>
  <Para id="_9">Enfortumab vedotin-ejfv
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Enfortumab Vedotin-ejfv</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/759429">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.38">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a620005.html">Enfortumab Vedotin-ejfv</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.39"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.40">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2023/bladder-cancer-padcev-keytruda-doubles-survival">Groundbreaking Trial Results Expand Treatment Options for Some People with Bladder Cancer Effects</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies">Monoclonal Antibodies</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C114500">Find Clinical Trials for Enfortumab Vedotin-ejfv</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2020-02-25</DateFirstPublished><DateLastModified>2023-12-15</DateLastModified></DrugInformationSummary>
